Neurocrine Biosciences (NBIX) Tops Q2 EPS by 50c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $156.76 +1.77%
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +30.8%
Financial Fact:
Total revenues: 0
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of $1.63, $0.50 better than the analyst estimate of $1.13. Revenue for the quarter came in at $580 million versus the consensus estimate of $547.1 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- United Community Banks completes $2B Navitas sale to Wafra
- MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
